Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2012
03/14/2012CN102370747A Compound Chinese medicinal preparation for treating obesity and preparation method thereof
03/14/2012CN102370716A Health-preserving health-care medicine of gynostemma pentaphylla and multiflower knotweed root
03/14/2012CN102370708A Application of extracts of Chinese herbal medicine mulberry leaf in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity
03/14/2012CN102370707A Method for preparing mulberry leaf and/or mulberry twig extract, obtained product thereof and application thereof
03/14/2012CN102370701A New application of compound red sage root tablet in treatment of Type 2 diabetes
03/14/2012CN102370694A Application of Chinese herbal medicine shrubby sophora extract to preparation of weight losing and lipid lowering medicament or medicament with lipase activity suppression effect
03/14/2012CN102370689A Application of extracts of Chinese herbal medicine folium sennae in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity
03/14/2012CN102370681A Application of extracts of Chinese herbal medicine rhizoma ligustici wallichii in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity
03/14/2012CN102370676A Application of extracts of Chinese herbal medicine fructus chebulae in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity
03/14/2012CN102370671A Active fraction in lucid ganoderma fruiting body, extracting method, application thereof and preparation
03/14/2012CN102370640A Compound amino acid preparation for hemodialysis and hemodialysis preparation containing same
03/14/2012CN102370630A Recombinant human growth hormone (rhGH) long-acting sustained-release microcapsule and preparation method thereof
03/14/2012CN102370628A Tetra-acetylated puerarin self-microemulsified sustained-release double-layer tablet and preparation method thereof
03/14/2012CN102370624A Exendin-4 sustained release microsphere, its injection and preparation method
03/14/2012CN102370612A Chitosan-monomethoxy polyethylene glycol gel delivery system and preparation method thereof
03/14/2012CN102370611A Temperature-sensitive hydrogel containing exendin-4 and injection thereof
03/14/2012CN102370589A Slimming cream and preparation method thereof
03/14/2012CN102370251A Preparing technique of health-care underwear
03/14/2012CN102370250A Health-care underwear
03/14/2012CN102085348B Preparation method and application of compound radix bupleuri preparation
03/14/2012CN102028900B Traditional Chinese medicine for treating metabolic syndrome and preparation method thereof
03/14/2012CN101890098B Medicament for treating type II diabetic cardiopathy and preparation method thereof
03/14/2012CN101856383B Liver-protecting white spirit and preparation method thereof
03/14/2012CN101843623B External fat-increasing preparation and application thereof
03/14/2012CN101745028B Drug for treatment of diabetes and complications thereof and preparation method thereof
03/14/2012CN101712671B Daizeol aliphatic ester derivatives, preparing method and medical application thereof
03/14/2012CN101496806B Use of compound extracted from bitter melon in preparing medicament for preventing and treating diabetes and fat disease
03/14/2012CN101450963B Gourd alkane type triterpene saponin compounds, medicament composition thereof as well as preparation method and application thereof
03/14/2012CN101439064B Nourishing tonic for sport
03/14/2012CN101312963B Glucagon receptor antagonists, preparation and therapeutic uses
03/14/2012CN101310621B Weight-reducing food and production method thereof
03/14/2012CN101306014B Use of brown algae polysaccharide sulfuric acid ester of low molecular weight in preparing medicine for treating diabetic nephropathy
03/14/2012CN101305758B Broussonetia papyrifera leaves tea and its preparation method
03/14/2012CN101121003B Vinegar with disease treating function and manufacturing method thereof
03/14/2012CN101098686B Glycogen synthase kinase-3 inhibitors
03/14/2012CN101096359B Polyaryl substituted methane oxygen or silica radical guanidine compound and preparation method and usage thereof
03/14/2012CN101039585B Mixture of phytosterol ester(s) and 1,3-diglyceride(s) for use in the treatment of medical conditions
03/13/2012US8133992 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
03/13/2012US8133980 Antibodies and functional fragments thereof that specifically bind an RF-amide peptide or a precursor thereof
03/13/2012US8133972 IgE antigenic peptides
03/13/2012US8133728 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/13/2012US8133726 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
03/13/2012CA2645574C A medicine used for curing hyperphosphatemia and its preparation method
03/13/2012CA2586056C Aryloxy-substituted benzimidazole derivative
03/13/2012CA2586023C Aliphatic amine polymer salts for tableting
03/13/2012CA2521254C Formulations for mediating inflammation and for reducing blood cholesterol
03/13/2012CA2486539C C-aryl glucoside sglt2 inhibitors and method
03/13/2012CA2435126C Process
03/13/2012CA2369074C Ether compounds, compositions, and uses thereof
03/08/2012WO2012031258A1 Recombinant t-cell receptor ligands with covalently bound peptides
03/08/2012WO2012030951A1 Fast-dissolve dosage forms of 5-ht2c agonists
03/08/2012WO2012030939A1 Administration of lorcaserin to individuals with renal impairment
03/08/2012WO2012030938A1 Salts of lorcaserin with optically active acids
03/08/2012WO2012030165A2 Use of the fetal reprogramming of a ppar δ agonist
03/08/2012WO2012030106A2 Production method of intermediate compound for synthesizing medicament
03/08/2012WO2012029958A1 Screening method for antidiabetic agent using newly identified insulin secretion regulation factor
03/08/2012WO2012029942A1 Cyclic amide derivative
03/08/2012WO2012029913A1 Oral preparation
03/08/2012WO2012029898A1 Mitigating agent for alcohol-induced problems
03/08/2012WO2012029870A1 Oligonucleotide, and therapeutic agent for dyslipidemia containing oligonucleotide as active ingredient
03/08/2012WO2012029722A1 Screening method
03/08/2012WO2012029529A1 Eggshell membrane solubilization method using enzymes
03/08/2012WO2012029326A1 3-pyrazolyl-2-pyridone derivative
03/08/2012WO2012029200A1 Orally administered composition having effect of improving serum lipids, and food/beverage composition
03/08/2012WO2012028563A1 Bace inhibitors for use in the treatment of diabetes
03/08/2012WO2012028335A2 Kinases as targets for anti-diabetic therapy
03/08/2012WO2012028331A1 Substituted tetrahydropyrrolopyrazine derivatives
03/08/2012WO2012028172A1 Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
03/08/2012WO2011161427A3 Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
03/08/2012WO2011153226A3 Cellular constituents from bacteroides, compositions thereof, and therapeutic methods employing bacteroides or cellular constituents thereof
03/08/2012WO2011146892A9 Methods and compositions for treating disorders associated with impaired insulin production or secretion
03/08/2012WO2011146518A3 Pegylated c-peptide
03/08/2012WO2011142621A3 Pharmaceutical formulation in the form of bilayered tablets comprising hmg-coa reductase inhibitor and irbesartan
03/08/2012WO2011138427A3 Pyridazinones as gpr119 agonists
03/08/2012WO2011130417A3 HUMAN FGF RECEPTOR AND β-KLOTHO BINDING PROTEINS
03/08/2012WO2011127482A3 Modulation of histone deacetylases for the treatment of metabolic disease, methods and compositions related thereto
03/08/2012WO2011126342A3 Novel use of polygonatum falcatum or polygonatum sibiricum extract
03/08/2012WO2011122815A3 Novel quinoxaline derivatives
03/08/2012WO2011122805A3 A composition comprising ajoene for preventing or treating a disease caused by overexpression of lxr-alpha
03/08/2012WO2003032894A3 Method of monitoring neuroprotective treatment
03/08/2012US20120060231 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody
03/08/2012US20120060230 Methods and compositions for modification of a hla locus
03/08/2012US20120059150 Methods for the production of apolipoproteins in transgenic plants
03/08/2012US20120059054 Use Of Copolymers Based On Amino-Containing Polymers As Matrix Binders In Preparing Active Compound-Containing Granules And Administration Forms
03/08/2012US20120059053 Compounds of 2,3-dihydro-benzofuran
03/08/2012US20120059052 Prenylflavonoid formulations
03/08/2012US20120059047 Differentiation modulating agents and uses therefor
03/08/2012US20120059046 Inhibition of map4k4 through rnai
03/08/2012US20120059040 NOVEL FORMS OF [R-(R*,R*)]-2-(4-FLUOROPHENYL)-beta,delta-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID MAGNESIUM
03/08/2012US20120059022 Crystalline Form of Bis[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoicacid] Calcium Salt
03/08/2012US20120059014 Compounds for the Treatment of Metabolic Disorders
03/08/2012US20120059012 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
03/08/2012US20120059011 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with pioglitazone
03/08/2012US20120059008 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders
03/08/2012US20120059006 Sigma receptor inhibitors
03/08/2012US20120059001 Novel kinase modulators
03/08/2012US20120058999 Substituted Tetrahydropyrrolopyrazine Compounds
03/08/2012US20120058998 Compounds, Compositions and Methods for the Treatment of Inflammatory Diseases
03/08/2012US20120058985 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
03/08/2012US20120058984 Pyrimidine derivatives used as itk inhibitors
1 ... 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 ... 1298